Clinical Trial Update: Risedronate Sodium in Post Menopausal Osteoporosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating risedronate sodium for postmenopausal osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• RISEDRONATE SODIUM (RISEDRONATE SODIUM)

Snippet

Sponsor: Sanofi | Conditions: Osteoporosis, Postmenopausal | Phase 4 | Status: COMPLETED